News and blogs
359 results found.
Looking back at a year of magic moments in blood cancer research
We look at our top 3 research moments from another incredible year.
Blood cancer UK reacts to £100m investment into regional hubs for clinical trials
We welcome the government’s investment of £100 million in public-private investment to establish 20 new Commercial Research Delivery Centres (CRDCs) across the UK.
Blood Cancer UK named BioIndustry Association's 2025 charity partner of the year
The BIA will support Blood Cancer UK through strategic opportunities and fundraising activities over the next 12 months.
Stem cell transplant research gives hope to those with blood cancer
Blood Cancer UK-funded researchers at the University of Birmingham have identified a key target, CD70, to reduce the likelihood of ‘graft-versus-host disease’ which people with blood cancer can develop after receiving a life-saving stem cell transplant.
How to make the most of the holiday season
People living with blood cancer share their tips about how to make the holiday season as festive as possible, while staying safe and relaxed.
Top 10 gifts for someone with blood cancer
What would someone with blood cancer like for Christmas? Read out top ten picks for things that might make a difference, whether in hospital or at home.
New blood cancer drugs in Scotland approved
Regulators in Scotland, has approved two new blood cancer treatments for use on the NHS in Scotland. A CAR-T therapy for diffuse large B-cell lymphoma is one of the treatments.
24 hour clubathon raises funds for friend on the Wirral
Friends from Wallasey, on the Wirral, will host a special 24-hour Clubathon event in support of one of their close-knit community Laura Parker, 35, who has an aggressive leukaemia, a form of blood cancer.
Interferon supplies for people with MPNs (Pegasys)
Find out what Blood Cancer UK is doing to solve the UK shortage of pegylated interferon alfa 2a (Pegasys), and what you can do if you take Pegasys to treat an MPN.
New life-changing myeloma drug given positive recommendation for fourth-line use on the NHS for those ‘exhausting’ options
The drug teclistamab (Tecvayli), has been recommended by NICE to treat myeloma, a form of blood cancer, in England and Wales.
Why at Blood Cancer UK we think the new investment towards improving cancer detection from the government is promising
The government has announced a number of new partnerships backed by public and private sector investment to tackle cancer and other life-threatening diseases with faster diagnoses and better treatments, deploying innovative technologies and approaches.
Dr Jewel Cobb – cancer researcher and champion of equality
Dr Jewel Plummer Cobb was an African American cell biologist and physiologist who contributed to pioneering research into cancer treatment.
A step forward for people with blood cancer
The drug quizartinib is now available for people with this specific form of blood cancer on the NHS in England.
World Cancer Research Day: our new research projects
We are funding eight new research projects we are funding taking our total number of research projects to 87 across the UK.
Mpox (monkeypox) and blood cancer
Find out about mpox, how it spreads, signs and symptoms, cases in the UK, and what it means for people with blood cancer.
Our Blood Cancer Action Plan to tackle blood cancer survival in the UK
Blood Cancer UK releases its comprehensive Action Plan "Taking blood cancer out of the shadows: A plan to increase survival in the UK"
Wales lags behind England in blood cancer survival
Our press release on our Blood Cancer Action Plan reveals how Wales is lagging behind England when it comes to blood cancer survival. Our landmark report is available to download in English and Welsh.
Ellie's blood cancer story
Ellie lived with acute myeloid leukaemia (AML). Her family are encouraging people to donate towards life-saving research.
Take at home tablet approved for blood cancer on NHS England
Zanubrutinib, is now available on the NHS in England for those with a type of blood cancer called marginal zone lymphoma.,
Drug, dasatinib approved for use on the NHS in Scotland
Dasatinib, is now approved for the treatment of adults with a form of leukaemia - Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) - on the NHS in Scotland.
